| Literature DB >> 32549983 |
Sy Duong-Quy1,2,3, Xuan Ngo-Minh3, Trinh Tang-Le-Quynh1, Tram Tang-Thi-Thao1, Bao Nguyen-Quoc1, Khiet Le-Quang1, Dinh Tran-Thanh1, Nhu Doan-Thi-Quynh1, Ethan Canty2, Toan Do2, Timothy Craig2.
Abstract
BACKGROUND: Medical face masks are integral personal protective equipment against infectious airborne disease and become scarce during epidemic outbreaks such as COVID-19. A novel, sustainably manufactured face mask with antimicrobial and anti-inflammatory properties from oil of Folium Plectranthii amboinicii can be an effective alternative to internationally sold masks.Entities:
Keywords: COVID-19; Filter paper mask; Folium Plectranthii amboinicii; mask shortage; pandemic
Year: 2020 PMID: 32549983 PMCID: PMC7282423 DOI: 10.4081/mrm.2020.664
Source DB: PubMed Journal: Multidiscip Respir Med ISSN: 1828-695X
Figure 1.Detail structure of LMC face mask. LMC, Lamdong Medical College.
Demographic and functional characteristics of study subjects.
| Subject characteristics (n=67) | Mean±SD or % (n) |
|---|---|
| Age, years | 39.4±10.2 |
| Male (female), % | 32.8 (67.2) |
| Height, cm | 159.6±6.9 |
| Weight, kg | 56.8±7.7 |
| BMI, kg/m2 | 26.4±2.9 |
| Administrative staff, % (n) | 14.9 (10/67) |
| Teacher, % (n) | 65.7 (44/67) |
| Other, % (n) | 19.4 (13/67) |
| High blood pressure, % (n) | 2.9 (2/67) |
| Arrhythmia or coronary disease, % (n) | 1.5 (1/67) |
| Diabetes, % (n) | 2.9 (2/67) |
| Rheumatology, % (n) | 2.9 (2/67) |
| Non, % (n) | 89.8 (60/67) |
| PEF, L/min | 431.7±92.2 |
| FENO, ppb | 12.5±6.8 |
| Mask wearing time, hours | 2.5±0.5 |
BMI, body mass index; PEF, peak expiratory flow; FENO, fractional concentration of nitric oxide in exhaled breath; ppb, part per billion.
Characteristics of study subjects defined by Group 1 and Group 2.
| Characteristics of research subjects | Group 1 (N=34) | Group 2 (N=33) | |
|---|---|---|---|
| Age, years | 38.7±9.7 | 40.1±10,. | NS |
| Male (female), % | 32.8 (67.2) | 36.3 (63.7) | NS |
| Height, cm | 160.1±6.3 | 159±7.5 | NS |
| Weight, kg | 56.7±7.3 | 57.0±8.1 | NS |
| BMI, kg/m2 | 25.6±2.8 | 27.0±2.8 | NS |
| Administrative staff, % (n) | 14.7(5) | 15.2(5) | NS |
| Teacher, % (n) | 64.7(22) | 66.7(22) | NS |
| Other, % (n) | 20.6(7) | 18.1(6) | NS |
| High blood pressure, % (N) | 2.9(1) | 3.0(1) | NS |
| Arrhythmia or coronary disease, % (N) | 2.9(1) | 3.0(1) | NS |
| Diabetes, % (N) | 2.9(1) | 0.0 (0) | NS |
| Rheumatology, % (N) | 2.9(1) | 3.0(1) | NS |
| Non, % (N) | 88.4 | 91.0 | NS |
| Peak flow, L/min | 430.3±85.2 | 433±99.1 | NS |
| FENO, ppb | 13.2±6.5 | 11.8±7.0 | NS |
| Mask wearing time, hours | 2.8±0.2 | 2.8±0.1 | NS |
BMI, body mass index; PEF, peak expiratory flow; FENO, fractional concentration of nitric oxide in exhaled breath; ppb, part per billion. Group 1, LMC mask use; Group 2, conventional mask use.
Figure 2.Comparison of PEF and FENO between Group 1 and Group 2 before mask use. PEF, peak expiratory flow; FENO, fractional concentration of nitric oxide in exhaled breath; ppb, part per billion; Group 1, LMC mask use; Group 2, conventional mask use.
Figure 3.Comparison of PEF and FENO between Group 1 and Group 2 after mask use. PEF, peak expiratory flow; FENO, fractional concentration of nitric oxide in exhaled breath; ppb, part per billion; Group 1, LMC mask use; Group 2, conventional mask use.
Comparison of modifications of PEF and FENO after mask use between Group 1 and 2.
| Parameters | Before mask use | After mask use | |
|---|---|---|---|
| Group 1 (n=34) | 430.3±85.2 | 435.5±76.9 | NS |
| Group 2 (n=33) | 433±99.1 | 428.2±104.6 | NS |
| Group 1 (n=34) | 13.2±6.5 | 8.2±4.2 | 0.01 |
| Group 2 (n=33) | 11.8±7.0 | 12.3±7.4 | NS |
PEF, peak expiratory flow; FENO, fractional concentration of nitric oxide in exhaled breath; ppb, part per billion. Group 1, LMC mask use; Group 2, conventional mask use.
Comparison of subjective symptoms of study subjects after mask use.
| Parameters | Group 1 (n=34) | Group 2 (n=33) | |
|---|---|---|---|
| 38.2(13) | 48.4(16) | NS | |
| Favorable effect | |||
| Clearer nasal passageways, % | 79.4(27) | 6.1(2) | <0.0001 |
| Nasal symptoms, % | 8.8(3) | 15.2(5) | NS |
| Sneezing, % | 5.9(2) | 6.1(2) | NS |
| Stuffy nose, % | 2.9(1) | 6.1(2) | NS |
| Runny nose, % | 0.0 (0) | 3.0(1) | NS |
| 2.9(1) | 18.2(6) | 0.020 | |
| Itchy throat, % | 2.9(1) | 12.1(4) | NS |
| Sore throat, % | 0.0 (0) | 6.1(2) | NS |
| 2.9(1) | 18.2(6) | 0.020 | |
| Cough, % | 2.9(1) | 15.2(5) | 0.009 |
| Difficulty breathing, % | 0.0 (0) | 3.0(1) | NS |
Group 1, LMC mask use; Group 2, conventional mask use.
Figure 4.Comparison of subjective symptoms of study subjects after mask use.